Vivos, Inc. (RDGL)
0.0453
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
Vivos Net Income (Quarterly) : -0.8302M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8302M |
| March 31, 2026 | -1.185M |
| December 31, 2025 | -1.078M |
| September 30, 2025 | -0.5073M |
| June 30, 2025 | -0.6455M |
| March 31, 2025 | -0.8347M |
| December 31, 2024 | -1.023M |
| September 30, 2024 | -0.8253M |
| June 30, 2024 | -0.5035M |
| March 31, 2024 | -0.5585M |
| December 31, 2023 | -1.076M |
| September 30, 2023 | -0.6677M |
| June 30, 2023 | -0.9025M |
| March 31, 2023 | -0.2483M |
| December 31, 2022 | -0.7057M |
| September 30, 2022 | -0.2771M |
| June 30, 2022 | -0.7875M |
| March 31, 2022 | -0.6999M |
| December 31, 2021 | -0.1782M |
| September 30, 2021 | -0.2012M |
| June 30, 2021 | -1.860M |
| March 31, 2021 | -0.2882M |
| December 31, 2020 | -0.3021M |
| September 30, 2020 | -0.1356M |
| June 30, 2020 | -0.1591M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3602M |
| December 31, 2019 | -0.504M |
| September 30, 2019 | -0.6694M |
| June 30, 2019 | -0.2003M |
| March 31, 2019 | -0.2364M |
| December 31, 2018 | 26.12M |
| September 30, 2018 | -26.91M |
| June 30, 2018 | -6.012M |
| March 31, 2018 | -0.9012M |
| December 31, 2017 | -2.625M |
| September 30, 2017 | -1.858M |
| June 30, 2017 | -1.519M |
| March 31, 2017 | -0.4168M |
| December 31, 2016 | 0.2899M |
| September 30, 2016 | -0.156M |
| June 30, 2016 | -4.183M |
| March 31, 2016 | -5.806M |
| December 31, 2015 | 0.6196M |
| September 30, 2015 | -2.531M |
| June 30, 2015 | 6.569M |
| March 31, 2015 | 1.575M |
| December 31, 2014 | -14.92M |
| September 30, 2014 | -0.8668M |
| June 30, 2014 | -1.236M |
| March 31, 2014 | -1.083M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 338.41M |
| Neogen Corp. | -11.30M |
| QuidelOrtho Corp. | -92.90M |
| Aspira Women's Health, Inc. | -2.42M |
| Biomerica, Inc. | -1.145M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0364M |
| Total Expenses (Quarterly) | 0.8666M |
| EPS Diluted (Quarterly) | -0.0017 |
| Enterprise Value | 29.49M |
| Gross Profit Margin (Quarterly) | -444.0% |
| Profit Margin (Quarterly) | -2.28K% |
| Earnings Yield | -17.23% |
| Normalized Earnings Yield | -14.36 |